Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Long‐Yan Yang"'
Autor:
Xin Wang, Ya-li Wu, Yuan-yuan Zhang, Jing Ke, Zong-wei Wang, Bao-yu Zhang, Yan Ma, Long-yan Yang, Dong Zhao
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 14, Iss 1, Pp 1-8 (2022)
Abstract Background AK098656 may be an adverse factor for coronary heart disease (CHD), especially in patients with hypertension. This study aimed to analyze the effect of AK098656 on CHD and CHD with various complications. Methods A total of 117 CHD
Externí odkaz:
https://doaj.org/article/7bb3db4d15a44bcf884e51c62c231d01
Autor:
Xin Wang, Jing Ke, Ying-jun Zhu, Bin Cao, Rui-li Yin, Yan Wang, Ling-ling Wei, Li-jie Zhang, Long-yan Yang, Dong Zhao
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract As a common chronic metabolic disease, the development of diabetes mellitus (DM) may also be accompanied by liver damage and inflammatory disorders. Sitagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP4, also known as CD26), which is c
Externí odkaz:
https://doaj.org/article/0ff91bd7af6943439fcf1c255221aa6b
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Fatty acid translocase CD36 (CD36) plays an important role in the initiation and pathogenesis of chronic liver disease and non-alcoholic fatty liver disease (NAFLD). The purpose of this study is to investigate the regulation of microRNA-20a-5p (miR-2
Externí odkaz:
https://doaj.org/article/a3b7ee0c76a04cd58504fa00cccf631c
Autor:
Long‐Yan Yang, Cai‐Guo Yu, Xu‐Hong Wang, Sha‐Sha Yuan, Li‐Jie Zhang, Jia‐Nan Lang, Dong Zhao, Ying‐Mei Feng
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 6 (2017)
BackgroundANGPTL4 (angiopoietin‐like protein 4) is a LPL (lipoprotein lipase) inhibitor and is present in high‐density lipoprotein (HDL). However, it is not defined whether ANGPTL4 in HDLs could affect HDL metabolism and function in type 2 diabet
Externí odkaz:
https://doaj.org/article/2a6e99c4b65442f2a4210da18f9916d5
Publikováno v:
Stem Cells International, Vol 2016 (2016)
Despite being featured as metabolic disorder, diabetic patients are largely affected by hyperglycemia-induced vascular abnormality. Accumulated evidence has confirmed the beneficial effect of endothelial progenitor cells (EPCs) in coronary heart dise
Externí odkaz:
https://doaj.org/article/437d64960c1445dba6c336ac68084521
Background: AK098656 may be an adverse factor for coronary heart disease (CHD), especially in patients with hypertension. This study aimed to analyze the effect of AK098656 on CHD and CHD with various complications.Methods: A total of 117 CHD patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66d186249426e1eb3099db3ec7accaaf
https://doi.org/10.21203/rs.3.rs-934224/v1
https://doi.org/10.21203/rs.3.rs-934224/v1
Autor:
Xin Wang, Ya-li Wu, Yuan-yuan Zhang, Jing Ke, Zong-wei Wang, Bao-yu Zhang, Yan Ma, Long-yan Yang, Dong Zhao
Publikováno v:
Diabetology & Metabolic Syndrome
Diabetology & Metabolic Syndrome, Vol 14, Iss 1, Pp 1-8 (2022)
Diabetology & Metabolic Syndrome, Vol 14, Iss 1, Pp 1-8 (2022)
Background AK098656 may be an adverse factor for coronary heart disease (CHD), especially in patients with hypertension. This study aimed to analyze the effect of AK098656 on CHD and CHD with various complications. Methods A total of 117 CHD patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8253523425e174ffca9dee6db03a95ac
https://pubmed.ncbi.nlm.nih.gov/35033179
https://pubmed.ncbi.nlm.nih.gov/35033179
Background: AK098656 may be an adverse factor for coronary heart disease (CHD), especially in patients with hypertension. This study aimed to analyze the effect of AK098656 on CHD and CHD with various complications.Methods: A total of 117 CHD patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2f4c17e4e5e5358a36cb05c1b694d67
https://doi.org/10.21203/rs.3.rs-85416/v1
https://doi.org/10.21203/rs.3.rs-85416/v1
Background and Purpose There are abundant hematopoietic stem cells (HSCs) in cord blood. It was known that HSCs continue to differentiate into common lymphoid progenitors (CLPs) and common myeloid progenitors (CMPs). Furthermore, the CMPs could diffe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::378f5374824c3c2a5fc5569dba4bfb64
https://doi.org/10.21203/rs.3.rs-48420/v1
https://doi.org/10.21203/rs.3.rs-48420/v1
Autor:
Dong Zhao1, Long-Yan Yang1, Xu-Hong Wang1, Sha-Sha Yuan1, Cai-Guo Yu1, Zong-Wei Wang1, Jia-Nan Lang1, Ying-Mei Feng1,2 yingmeif13@sina.com
Publikováno v:
Cardiovascular Diabetology. 9/13/2016, Vol. 15, p1-15. 15p. 4 Charts, 5 Graphs.